{"bill": {"#text": "\n\t", "form": {"current-chamber": {"#tail": "\n\t\t", "#text": "IN THE SENATE OF THE UNITED STATES"}, "#text": "\n\t\t", "congress": {"#tail": "\n    ", "#text": "113th CONGRESS"}, "#tail": "\n\t", "legis-num": {"#tail": "\n\t\t", "#text": "S. 2549"}, "official-title": {"#tail": "\n\t", "#text": "To amend the Federal Food, Drug, and Cosmetic Act to allow for the personal importation of safe and\n\t\t\t affordable drugs from approved pharmacies in Canada."}, "session": {"#tail": "\n\t\t", "#text": "2d Session"}, "distribution-code": {"#tail": "\n\t\t", "@display": "yes", "#text": "II"}, "action": {"action-date": {"#tail": "\n\t\t\t", "@date": "20140626", "#text": "June 26, 2014"}, "#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "committee-name": {"#tail": "\n      ", "@committee-id": "SSHR00", "#text": "Committee on Health, Education, Labor, and Pensions"}, "sponsor": {"#tail": " (for herself and ", "#text": "Ms. Klobuchar", "@name-id": "S311"}, "cosponsor": {"#tail": ") introduced the following bill; which was read twice and referred to the ", "#text": "Mr. McCain", "@name-id": "S197"}}, "#text": "\n\t\t\t"}, "legis-type": {"#tail": "\n\t\t", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-Senate", "@dms-id": "A1", "@public-private": "public", "legis-body": {"#tail": "\n", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n\t\t", "quote": {"short-title": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "act", "#text": "Safe and Affordable Drugs from Canada Act of 2014", "@value": "Safe and Affordable Drugs from Canada Act of 2014", "@proposed": "true"}, "#text": "\n            "}, "#tail": ".", "#text": "\n          "}, "#text": "This Act may be cited as the\n\t\t  ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n\t\t\t", "#text": "Short title"}, "#text": "\n      ", "@id": "S1"}, {"#tail": "\n  ", "text": {"#tail": "\n      ", "#text": "\n        ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by\n\t\t\t adding at the end the following:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Chapter VIII of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/ch:VIII"}, "@entity-type": "law-citation", "#text": "\n          ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n        ", "@entity-type": "uscode", "#text": "21 U.S.C. 381 et seq.", "@value": "usc/21/381/etseq"}, "@parsable-cite": "usc/21/381", "#text": "\n          ", "@legal-doc": "usc"}}, "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n      ", "#text": "Safe and affordable drugs from Canada"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n      ", "#text": "."}, "#tail": "\n\t\t", "section": {"#tail": "\n        ", "enum": {"#tail": "\n          ", "#text": "810."}, "header": {"#tail": "\n          ", "#text": "Importation by individuals of prescription drugs from Canada"}, "subsection": [{"#tail": "\n          ", "text": {"#tail": "\n          ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall promulgate regulations\n\t\t\t permitting individuals to safely import into the United States a\n\t\t\t prescription drug described in ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "act", "#text": "subsection (b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:810/ss:b", "@proposed": "true"}], "#text": "Notwithstanding any other provision of this Act, not later than 180 days after the date of\n\t\t\t enactment of this section, the "}, "enum": {"#tail": "\n            ", "#text": "(a)"}, "header": {"#tail": "\n            ", "#text": "In general"}, "#text": "\n            ", "@id": "id33ce38dcf8e7430ab08fec11acfca021"}, {"#tail": "\n          ", "text": {"#tail": "\n            ", "#text": "A prescription drug described in this subsection\u2014"}, "enum": {"#tail": "\n            ", "#text": "(b)"}, "header": {"#tail": "\n            ", "#text": "Prescription drug"}, "paragraph": [{"#tail": "\n            ", "text": {"#tail": "\n              ", "#text": "is a prescription drug that\u2014"}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "#text": "\n              ", "@id": "id0DC9EA87C05B4E468E7FF626467560AA", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n              ", "#text": "is purchased from an approved Canadian pharmacy;"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "id96bd01ac2b9145279c287e30d10bfeb4", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n              ", "#text": "is dispensed by a pharmacist licensed to practice pharmacy and dispense prescription drugs in\n\t\t\t Canada;"}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "idc29c4e47bbc4452da50ce5d837551c60", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n              ", "#text": "is purchased for personal use by the individual, not for resale, in quantities that do not exceed a\n\t\t\t 90-day supply;"}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "@id": "idabb20122b0304ef2a37dad95b70dd0c5", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n              ", "#text": "is filled using a valid prescription issued by a physician licensed to practice in a State in the\n\t\t\t United States; and"}, "enum": {"#tail": "\n                ", "#text": "(D)"}, "@id": "id23541c8a98fe4aa7973afcc757b388bc", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n              ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": "; and", "@entity-type": "act", "#text": "chapter V", "@value": "Federal Food, Drug, and Cosmetic Act/ch:V"}], "#text": "has the same active ingredient or ingredients, route of administration, dosage form, and strength\n\t\t\t as a prescription drug approved by the "}, "enum": {"#tail": "\n                ", "#text": "(E)"}, "@id": "id6f615d8cdb584ac29ee7f68d4143928a", "#text": "\n                "}]}, {"#tail": "\n          ", "text": {"#tail": "\n              ", "#text": "does not include\u2014"}, "enum": {"#tail": "\n              ", "#text": "(2)"}, "#text": "\n              ", "@id": "id080b371792344874bb271bf276133a32", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n              ", "#text": "a controlled substance (as defined in ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ");", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "section 102 of the Controlled Substances Act", "@value": "Controlled Substances Act/s:102"}, {"#tail": ")", "@entity-type": "uscode", "#text": "21 U.S.C.\n\t\t\t 802", "@value": "usc/21/802"}], "@entity-type": "law-citation", "#text": "\n                    "}}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "ida9f34eddf4b54d208f938b7c47dc8f6e", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n              ", "#text": "a biological product (as defined in ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ");", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 351 of the Public Health Service Act", "@value": "Public Health Service Act/s:351"}, "@entity-type": "law-citation", "#text": "\n                    ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                  ", "@entity-type": "uscode", "#text": "42 U.S.C. 262", "@value": "usc/42/262"}, "@parsable-cite": "usc/42/262", "#text": "\n                    ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "idadf8273e252448429a1eae7cd2aa5671", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n              ", "#text": "an infused drug (including a peritoneal dialysis solution);"}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "@id": "id75570dda7f234c3e829b438b0d566821", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n              ", "#text": "an intravenously injected drug;"}, "enum": {"#tail": "\n                ", "#text": "(D)"}, "@id": "ideabf91f7f74841f786682f63ae3721a2", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n              ", "#text": "a drug that is inhaled during surgery;"}, "enum": {"#tail": "\n                ", "#text": "(E)"}, "@id": "ide7a9734353324f6d8331e683e162a9db", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n              ", "#text": "a parenteral drug;"}, "enum": {"#tail": "\n                ", "#text": "(F)"}, "@id": "id648905d845a74e54bcfaa93e242bd1fd", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n                ", "#text": "a drug manufactured through 1 or more biotechnology processes, including\u2014"}, "enum": {"#tail": "\n                ", "#text": "(G)"}, "clause": [{"#tail": "\n                ", "text": {"#tail": "\n                ", "#text": "a therapeutic DNA plasmid product;"}, "enum": {"#tail": "\n                  ", "#text": "(i)"}, "@id": "id54eab55e3cfb46a0a96c165f8d97719f", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n                ", "#text": "a therapeutic synthetic peptide product of not more than 40 amino acids;"}, "enum": {"#tail": "\n                  ", "#text": "(ii)"}, "@id": "id0fc9db23d6d247d8926d79d5991989dd", "#text": "\n                  "}, {"#tail": "\n                ", "text": {"#tail": "\n                ", "#text": "a monoclonal antibody product for in vivo use; and"}, "enum": {"#tail": "\n                  ", "#text": "(iii)"}, "@id": "id5ca1aa42aa364b6f9d7609cf101019b7", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n                ", "#text": "a therapeutic recombinant DNA-derived product;"}, "enum": {"#tail": "\n                  ", "#text": "(iv)"}, "@id": "idc7ea61bbb38647f5819f57baef263b33", "#text": "\n                  "}], "#text": "\n                ", "@id": "id3c0f78d0181443d4a7c2a8c160ea3905"}, {"#tail": "\n              ", "text": {"#tail": "\n              ", "#text": "a drug required to be refrigerated at any time during manufacturing, packing, processing, or\n\t\t\t holding; or"}, "enum": {"#tail": "\n                ", "#text": "(H)"}, "@id": "id6cb89c156cd1434ea22d4bd19b1bb459", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n              ", "#text": "a photoreactive drug."}, "enum": {"#tail": "\n                ", "#text": "(I)"}, "@id": "id65f996a1442641a18a8af89e1a289d91", "#text": "\n                "}]}], "#text": "\n            ", "@id": "idF66486A9E01547EE9E748A42F77BF847"}, {"#tail": "\n        ", "enum": {"#tail": "\n            ", "#text": "(c)"}, "header": {"#tail": "\n            ", "#text": "Approved Canadian pharmacy"}, "paragraph": [{"#tail": "\n            ", "@id": "ida5d18d015b99429f8db4ecf097c7852b", "enum": {"#tail": "\n              ", "#text": "(1)"}, "header": {"#tail": "\n              ", "#text": "In general"}, "text": {"#tail": "\n              ", "#text": "In this section, an approved Canadian pharmacy is a pharmacy that\u2014"}, "#text": "\n              ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n              ", "#text": "is located in Canada; and"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "id477e7f1dca184031aaab95902cdf388c", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " certifies\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "that the "}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "clause": [{"#tail": "\n                ", "text": {"#tail": "\n                ", "#text": "is licensed to operate and dispense prescription drugs to individuals in Canada; and"}, "enum": {"#tail": "\n                  ", "#text": "(i)"}, "@id": "id2053d0aed50d4ee2ae8cc0d1f1a4260f", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "paragraph (3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:810/ss:c/p:3", "@proposed": "true"}, "#text": "meets the criteria under "}, "enum": {"#tail": "\n                  ", "#text": "(ii)"}, "@id": "id093e331404fc442c91be4d484be185a2", "#text": "\n                  "}], "#text": "\n                ", "@id": "ideb55d3b98ae042269e76f70a4fe19b76"}]}, {"#tail": "\n            ", "text": {"#tail": "\n            ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall publish on the Internet Web site of the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " a list of\n\t\t\t approved Canadian pharmacies, including the Internet Web site address of\n\t\t\t each such approved Canadian pharmacy, from which individuals may purchase\n\t\t\t prescription drugs in accordance with ", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}, {"#tail": ".", "@entity-type": "act", "#text": "subsection (a)", "@value": "Federal Food, Drug, and Cosmetic Act/s:810/ss:a", "@proposed": "true"}], "#text": "The "}, "enum": {"#tail": "\n              ", "#text": "(2)"}, "header": {"#tail": "\n              ", "#text": "Publication of approved canadian pharmacies"}, "#text": "\n              ", "@id": "id9d7eb12c74494581b465e723c69ed10e"}, {"#tail": "\n          ", "@id": "id85cfc85f021c435bb406ff4e5bb7e09a", "enum": {"#tail": "\n              ", "#text": "(3)"}, "header": {"#tail": "\n              ", "#text": "Additional criteria"}, "text": {"#tail": "\n              ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall certify that the pharmacy\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "To be an approved Canadian pharmacy, the "}, "#text": "\n              ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n              ", "#text": "has been in existence for a period of at least 5 years preceding the date of such certification and\n\t\t\t has a purpose other than to participate in the program\n\t\t\t established under this section;"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "id12acaa80c34c42969e9110ea830613c7", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n              ", "#text": "operates in accordance with pharmacy standards set forth by the provincial pharmacy rules and\n\t\t\t regulations enacted in Canada;"}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "id6b391c716b7c4fffb90d41c3ca5eceea", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n              ", "#text": "has processes established by the pharmacy, or participates in another established process, to\n\t\t\t certify that the physical premises and data reporting procedures and\n\t\t\t licenses are in compliance with all applicable laws and regulations, and\n\t\t\t has implemented policies designed to monitor ongoing compliance with such\n\t\t\t laws and regulations;"}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "@id": "id40e4c0202582445fbf5a33090e287cd1", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n              ", "#text": "conducts or commits to participate in ongoing and comprehensive quality assurance programs and\n\t\t\t implements such quality assurance measures, including blind testing, to\n\t\t\t ensure the veracity and reliability of the findings of the quality\n\t\t\t assurance program;"}, "enum": {"#tail": "\n                ", "#text": "(D)"}, "@id": "id9271d3f4ea46470ca6102c60ea557726", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n              ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall be used to conduct product testing to\n\t\t\t determine the safety and efficacy of sample pharmaceutical products;", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "agrees that laboratories approved by the "}, "enum": {"#tail": "\n                ", "#text": "(E)"}, "@id": "id571531bf23a448df990976daabd442cd", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n              ", "#text": "has established, or will establish or participate in, a process for resolving grievances and will\n\t\t\t be held accountable for violations of established guidelines and rules;"}, "enum": {"#tail": "\n                ", "#text": "(F)"}, "@id": "idce04c7fb8cb34db8b46644264aae86c6", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n              ", "#text": "does not resell products from online pharmacies located outside Canada to customers in the United\n\t\t\t States; and"}, "enum": {"#tail": "\n                ", "#text": "(G)"}, "@id": "idbe2ef902f3af4333aba0839dea081669", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n              ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "meets any other criteria established by the "}, "enum": {"#tail": "\n                ", "#text": "(H)"}, "@id": "id5e4c0a7901a346678603690f162f854e", "#text": "\n                "}]}], "#text": "\n            ", "@id": "iddc557636ff9d466993f81250425c7b2f"}], "#text": "\n          ", "@id": "id189b738c0cac476a9d2d54663246c60e"}, "@display-inline": "no-display-inline", "#text": "\n        ", "@id": "idf48230954e2043029ec94f5f5f54478e"}, "#text": "\n      ", "@id": "idD62F459942DF49B59FB3157554963F65"}], "#text": "\n\t\t"}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n", "#text": "2014-06-26"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 S2549 IS: Safe and Affordable Drugs from Canada Act of 2014"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. Senate"}, "#text": "\n"}, "#text": "\n"}}}